When a wound occurs, several changes take place to minimize blood loss. First, the
blood vessel slows the flow of blood past the wound site. Next, platelets collect at
the wound site to form a plug. Finally, fibrin clots form scabs to replace these
temporary platelet plugs.
The coagulation, or clotting, factors are necessary for fibrin clot formation. Most
coagulation defects result in a coagulation factor deficiency and increased bleeding.
However, a newly discovered inherited disorder has been found which is produced by the
factor V Leiden mutation, a change in the gene producing coagulation factor V. This
mutation produces an abnormal factor V that cannot be destroyed in the bloodstream,
leading to excess clotting and increased risk of thrombosis (clot formation, often
blocking important blood vessels). Factor V Leiden produces an inherited disorder that is
present in 4 to 6 percent of the population. Patients with the mutation have a three- to
six-fold increased risk of developing thrombosis. In addition, their risk of thrombosis is
higher if other risk factors are present than it is in normal patients with the same risk
factors. These risk factors include injury, surgery, advanced age, oral contraceptives,
and other genetic deficiencies (i.e. protein C and protein S). The disorder is
detected by laboratory testing. More research must be done to determine the best treatment
for the disorder. However, anticoagulation therapy using
heparin or
warfarin (Coumadin) or
fibrinolytic therapy may be effective.